2012
DOI: 10.1590/s1516-31802012000100007
|View full text |Cite
|
Sign up to set email alerts
|

Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection

Abstract: CONTEXT AND OBJECTIVES: Resistant bacteria are emerging worldwide as a threat to favorable outcomes from treating common infections in community and hospital settings. The present investigation was carried out to study the incidence of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in patients with urinary tract infection in different seasons of the year, in order to determine the prevalence of the genes blaTEM, blaSHV and blaCTX-M, which are responsible for ESBL production among ESBL-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(15 citation statements)
references
References 18 publications
(13 reference statements)
2
12
0
1
Order By: Relevance
“…In our present study, two isolates (K1 and K2) of K.pneumoniae had plasmid molecular weight of 982 kb. This plasmid likely to bear high antibiotic resistance encoding beta-lactamse enzyme confer resistance to ampicilin, kanamycin, chloramphenicol [35,36]. Our present study found majority of isolates (80%) resistant to antibiotic ampicilin, 70% resistant to chloramphenicol and kanamycin.…”
Section: In -Vitro Assay For Virulence Factorssupporting
confidence: 53%
“…In our present study, two isolates (K1 and K2) of K.pneumoniae had plasmid molecular weight of 982 kb. This plasmid likely to bear high antibiotic resistance encoding beta-lactamse enzyme confer resistance to ampicilin, kanamycin, chloramphenicol [35,36]. Our present study found majority of isolates (80%) resistant to antibiotic ampicilin, 70% resistant to chloramphenicol and kanamycin.…”
Section: In -Vitro Assay For Virulence Factorssupporting
confidence: 53%
“…Previously, the rates of bla SHV containing Enterobacterales with a focus on uropathogenic isolates were reported 12.2% to 54.8% by Iranian authors. [24][25][26][27][28][29] Meanwhile, several authors have shown the global spared of SHV type β-lactamases in uro- pathogenic Enterobacterales from China, 30 India, 31 Saudi Arabia, 32 Turkey, 33 Ukraine, 34 and Morocco. 35 In our results, 4.1% of uropathogenic Enterobacterales contained bla NDM-1, which to the best of our knowledge, is the first prevalence of this gene in Guilan province (North of Iran).…”
Section: Discussionmentioning
confidence: 99%
“…The high prevalence of ESBL producing E. coli isolates from outpatients calls for the need to aware of this increasing resistance between uropathogens and update bacterial susceptibility data and to set up our empirical therapy accordingly. [9].Treatment of infections caused by ESBLproducing bacteria has become a world problem and has led to an increase in the death of patients, as well as a greater financial burden for treatment [10]. Because of rising antibiotic resistance between organisms and the high prevalence of ESBL producing E. coli in the community and its importance in managing UTIs, local hospital-based knowledge of the uropathogens and their antibiotic susceptibility pattern is necessary and helpful for physicians to choose appropriate empirical treatment [11,12].…”
Section: Introductionmentioning
confidence: 99%